Search

Your search keyword '"HUS Comprehensive Cancer Center"' showing total 435 results

Search Constraints

Start Over You searched for: Author "HUS Comprehensive Cancer Center" Remove constraint Author: "HUS Comprehensive Cancer Center" Topic 3. good health Remove constraint Topic: 3. good health
435 results on '"HUS Comprehensive Cancer Center"'

Search Results

1. Immunogenomic Landscape of Hematological Malignancies

2. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden

3. Sortilin‐related receptor is a druggable therapeutic target in breast cancer

4. Twelve Years of Postgraduate Palliative Medicine Training in Finland: How International Guidelines Are Implemented

5. Global, regional, and national burden of bone fractures in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

6. CIP2A interacts with TopBP1 and drives basal-like breast cancer tumorigenesis

7. Expression of markers of stem cell characteristics, epithelial-mesenchymal transition, basal-like phenotype, proliferation, and androgen receptor in metaplastic breast cancer and their prognostic impact

8. Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients

9. Von Willebrand Factor Multimeric Assay in Acquired von Willebrand Disease Diagnosis: A Report of Experience from North Estonia Medical Centre

10. Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation

11. Prognostic Value of Apparent Diffusion Coefficient in Oropharyngeal Carcinoma

12. Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis

13. Long-term outcome after allogeneic stem cell transplantation in multiple myeloma

14. Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B‐NORD study

15. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study

16. Soft Tissue Sarcoma of Lower Extremity: Functional Outcome and Quality of Life

17. Prognostic significance of esterase gene expression in multiple myeloma

18. Second Primary Cancers After Kidney Cancers, and Kidney Cancers as Second Primary Cancers

19. Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes

20. The utilization of specialized healthcare services among frail older adults in the Helsinki Birth Cohort Study

21. Validity of five foot and ankle specific electronic patient-reported outcome (ePRO) instruments in patients undergoing elective orthopedic foot or ankle surgery

22. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the global burden of disease study 2020, release 1

23. The DLBCL90 gene‐expression assay identifies double‐hit lymphomas with high sensitivity in patients from two phase II clinical trials with high‐risk diffuse large B‐cell lymphoma

24. The role of polygenic risk and susceptibility genes in breast cancer over the course of life

25. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

26. Rate differences between first and second primary cancers may outline immune dysfunction as a key risk factor

27. Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes

28. Heparin Dose and Point-of-Care Measurements of Hemostasis in Cardiac Surgery—Results of a Randomized Controlled Trial

29. Impact of central nervous system (CNS) prophylaxis on the incidence of CNS relapse in patients with high-risk diffuse large B cell/follicular grade 3B lymphoma

30. Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain

31. Rivaroxaban versus aspirin for secondary prevention of ischaemic stroke in patients with cancer: a subgroup analysis of the NAVIGATE ESUS randomized trial

32. Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families

33. ARX788, a novel anti-HER2 antibody-drug conjugate, shows anti-tumor effects in preclinical models of trastuzumab emtansine-resistant HER2-positive breast cancer and gastric cancer

34. Itraconazole Increases Ibrutinib Exposure 10‐Fold and Reduces Interindividual Variation—A Potentially Beneficial Drug‐Drug Interaction

35. Falls in older aged adults in 22 European countries: incidence, mortality and burden of disease from 1990 to 2017

36. Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma

37. Mutation accumulation in cancer genes relates to nonoptimal outcome in chronic myeloid leukemia

38. Bevacizumab as adjuvant treatment of colon cancer: updated results from the S-AVANT phase III study by the GERCOR Group

39. Novel Hemizygous IL2RG p.(Pro58Ser) Mutation Impairs IL-2 Receptor Complex Expression on Lymphocytes Causing X-Linked Combined Immunodeficiency

40. Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients

41. Quantifying risks and interventions that have affected the burden of lower respiratory infections among children younger than 5 years

42. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis for the Global Burden of Disease Study 2016

43. Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

44. Local therapy with an engineered oncolytic adenovirus enables antitumor response in non-injected melanoma tumors in mice treated with aPD-1

45. Measuring functional outcome in upper extremity soft-tissue sarcoma : Validation of the Toronto extremity salvage score and the QuickDASH patient-reported outcome instruments

46. Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma:The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience

47. Comparison of vacuum-assisted excision (VAE) and breast lesion excision system (BLES) in the treatment of intraductal papillomas

48. Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

49. A Mendelian randomization analysis of circulating lipid traits and breast cancer risk

50. Prediction and clinical utility of a contralateral breast cancer risk model

Catalog

Books, media, physical & digital resources